Translational Research

More About Translational Research at Tech

Translational Research Institute for Biomedical Engineering & Science (TRIBES)

The Translational Research Institute for Biomedical Engineering and Science (TRIBES) links biomedical research and educational activities at Georgia Tech with key medical institutions and organizations to provide critical capabilities for pre-commercial engineering development activities for license and transition of technology into industry for the benefit of diagnosis and treatment of patients in the healthcare system.

Scientific discoveries must be translated into practical applications. Translational research is a research approach that moves “from bench to bedside” or from laboratory experiments through clinical trials to actual point-of-care patient applications. Such discoveries typically begin at “the bench” with basic research — in which scientists study disease at a molecular or cellular level — then progress to the clinical level, or the patients' “bedside.” 

Barbara Boyan, Associate Dean for Research and colleagues

  • COE has formed the Center for Innovative Cardiovascular Technologies. Dr. Ajit Yoganathan, Wallace H. Coulter Distinguished Chair in Biomedical Engineering at Georgia Tech and Emory University and Regents' Professor, will serve as the center's founding director. The center will focus on developing and enhancing cutting-edge cardiovascular therapies and train the next generation of cardiovascular technology innovators.

  • The National Institutes of Health (NIH) has awarded more than $31 million over five years--one of the largest NIH grants in Georgia's history to a partnership of Atlanta academic, research and healthcare institutions focused on accelerating the translation of laboratory discoveries into healthcare innovations for patients. The partnership, named the Atlanta Clinical and Translational Science Institute (ACTSI), is led by Emory University, along with Morehouse School of Medicine, the Georgia Institute of Technology and Children's Healthcare of Atlanta.

  • Supported by a $10 million endowment from the Coulter Foundation, a biomedical engineering research program partners biomedical engineers with clinicians in a collaborative effort to solve complex problems for the benefit of humanity. From receiving patents to launching new companies and attracting capital, the program has become the template for the Coulter Foundation's National Translational Research Partnership Program.

  • The first of its kind in the Southeast, the Global Center for Medical Innovation (GCMI) will include a comprehensive medical device prototyping center. Supported by the Georgia Institute of Technology, Saint Joseph's Translational Research Institute (SJTRI), Piedmont Healthcare and the Georgia Research Alliance (GRA), the new center will bring together the complete medical device marketplace which includes universities, research centers and clinicians; established drug and device companies; investors, and early-stage companies.